It could inhibit the methylation of the whole genome and specific genes in human colon cancer HCT116 cell and breast cancer MCF7 cell effectively, which is dependent on the activity of DNMT1 degradation (Brueckner et al., 2010). This evidence concerns the gene DNMT1 and colonic neoplasm.